What Medications Interact With Vitamin D Supplements?
At a Glance
Most people taking standard vitamin D doses have no important medication interaction, but antiseizure drugs, steroids, rifampin, orlistat, bile-acid medicines, thiazides, and digoxin may require dose timing or monitoring, especially with high doses, calcium, or kidney disease.
In this answer
4 sections
Yes, vitamin D supplements can interact with several common prescription medicines. Fortunately, most people taking standard recommended doses of vitamin D do not experience clinically important medication interactions [1]. However, if you require higher-dose replacement therapy, take calcium supplements, or have kidney disease, these interactions become more relevant [2] [3].
Some medications lower your vitamin D levels or change how your body processes it, meaning your clinician may need to adjust your supplement dose [4]. Other medicines interfere with how well your body absorbs vitamin D from your digestive tract, which requires dietary fat and bile to be absorbed [5]. Conversely, taking high doses of vitamin D (especially with calcium) can raise your blood calcium levels, which can increase the risks associated with certain heart and blood pressure medications [3].
Below are the most important types of medications that interact with vitamin D. This is not an exhaustive list.
Medicines That Alter Vitamin D Metabolism
Certain medications speed up or change how the liver and kidneys process vitamin D. Just because you take one of these medicines does not automatically mean you need extra vitamin D; your doctor will individualize your dose and monitor your 25-hydroxyvitamin D blood level if needed [6].
- Enzyme-inducing antiseizure medicines: Drugs such as phenytoin, carbamazepine, and phenobarbital can change vitamin D metabolism and are linked to lower vitamin D levels [7] [8]. Because these medicines disturb vitamin D and calcium metabolism, long-term use can contribute to drug-induced osteoporosis (bone loss) [9].
- Glucocorticoids: Long-term use of steroids (such as prednisone) can reduce how much calcium your body absorbs from your intestines, increase calcium loss, and suppress bone formation [4]. Glucocorticoids independently cause rapid bone loss and increase fracture risk [10]. Your clinician might suggest a bone-density (DEXA) scan to evaluate this risk [4].
- Rifampin: This antibiotic, commonly used to treat tuberculosis, alters liver enzyme pathways that break down vitamin D [11] [12]. While studies in humans show varied effects, rifampin can change your body’s vitamin D requirements [13].
- Antiretroviral medicines: Used to treat HIV, their effects on vitamin D vary widely depending on the specific regimen and how long you have been taking it [14]. Because these effects differ so much by drug, you should not assume all antiretrovirals have the same impact on your vitamin D levels [15].
Medicines That Reduce Vitamin D Absorption
Medications that affect how your body digests fats or bile can reduce how much vitamin D you absorb from your supplement. Note that separating your doses fixes absorption issues, but it will not correct the metabolic interactions (like with antiseizure medicines) discussed above.
- Orlistat: This weight-loss medication inhibits lipases (gastrointestinal enzymes) from digesting fats. Because it stops fat digestion, it reduces the absorption of fat-soluble vitamins like vitamin D, and product labeling often advises taking vitamin D supplements at a different time of day [16].
- Bile-acid sequestrants: Cholesterol-lowering medicines, such as cholestyramine, work by binding to bile acids in your small intestine [5]. Your body needs bile to absorb fat-soluble nutrients, so taking these medications at the same time as vitamin D can block the vitamin’s absorption [17].
Medicines Affected by High Calcium Levels (Hypercalcemia)
Taking excessive amounts of vitamin D supplements—especially when combined with calcium supplements—can sometimes lead to hypercalcemia (abnormally high calcium levels in the blood) [18] [19]. While uncommon with normal replacement doses, high blood calcium can complicate certain therapies:
- Thiazide diuretics: These common blood pressure medications reduce how much calcium your kidneys excrete. When combined with high doses of vitamin D or calcium supplements, thiazides may increase the risk of hypercalcemia, especially in people with kidney issues [3].
- Digoxin: This medicine treats heart failure and irregular heartbeats. If your blood calcium levels become too high (hypercalcemia) while taking digoxin, it can increase your susceptibility to severe cardiac arrhythmias or digoxin toxicity [20]. If you take digoxin, your clinician may decide to monitor your blood calcium, kidney function, and electrolytes [21].
Safety Warning: Never stop taking your heart or blood pressure medications without professional advice. If you take digoxin and vitamin D and develop symptoms like persistent nausea, vomiting, unusual weakness, confusion, visual changes, or an irregular heartbeat, seek urgent medical help [20] [22].
Talk to Your Care Team
When you are treating a vitamin D deficiency or starting a new supplement, provide your healthcare providers with a complete list of all your prescription medications, over-the-counter drugs, antacids, and herbal supplements [6]. Ask a pharmacist or clinician before changing your doses. If you take medicines that block absorption (like cholestyramine or orlistat), ask your pharmacist for specific dose-separation instructions, as the timing differs for each product [16] [17].
Common questions in this guide
Do vitamin D supplements interact with prescription medicines?
Which medications can lower vitamin D levels?
Should I take vitamin D at a different time from orlistat or cholestyramine?
Can I take vitamin D with thiazide diuretics or digoxin?
What symptoms could signal a serious vitamin D interaction?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Do any of my current prescriptions change how my body processes or absorbs vitamin D?
- 2.What dose and form of vitamin D should I take, when should my 25-hydroxyvitamin D and calcium be rechecked, and should I avoid extra calcium?
- 3.If I take a medicine that blocks absorption, exactly how many hours should I wait between taking that drug and my vitamin D supplement?
- 4.I am taking a medicine that affects bone density; based on my age, medication duration, and fracture history, should I have a bone-density (DEXA) scan?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (22)
- 1
Too much vitamin D? a drug safety review.
Cianferotti L, Bilezikian JP, Bifolco G, et al.
Reviews in endocrine & metabolic disorders 2026; (27(1)):167-181 doi:10.1007/s11154-025-10011-8.
PMID: 41483069 - 2
Vitamin D supplementation: upper limit for safety revisited?
Rizzoli R
Aging clinical and experimental research 2021; (33(1)):19-24 doi:10.1007/s40520-020-01678-x.
PMID: 32857334 - 3
Hypercalcemia: A Review.
Walker MD, Shane E
JAMA 2022; (328(16)):1624-1636 doi:10.1001/jama.2022.18331.
PMID: 36282253 - 4
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club.
Laurent MR, Goemaere S, Verroken C, et al.
Frontiers in endocrinology 2022; (13()):908727 doi:10.3389/fendo.2022.908727.
PMID: 35757436 - 5
Bile Acid Sequestrants Based on Natural and Synthetic Gels.
Stanciu MC, Nichifor M, Teacă CA
Gels (Basel, Switzerland) 2023; (9(6)) doi:10.3390/gels9060500.
PMID: 37367171 - 6
Reference values of 25-hydroxyvitamin D revisited: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society of Clinical Pathology/Laboratory Medicine (SBPC).
Moreira CA, Ferreira CEDS, Madeira M, et al.
Archives of endocrinology and metabolism 2020; (64(4)):462-478 doi:10.20945/2359-3997000000258.
PMID: 32813765 - 7
Vitamin D deficiency in a Portuguese epilepsy cohort: who is at risk and how to treat.
Cunha IA, Saraiva AM, Lopes P, et al.
Epileptic disorders : international epilepsy journal with videotape 2021; (23(2)):291-298 doi:10.1684/epd.2021.1268.
PMID: 33875410 - 8
Prevalence and predictors of vitamin D deficiency among adults with epilepsy: A cross-sectional study.
Khoo CS, Shukor MF, Tan JK, et al.
Epilepsy & behavior : E&B 2023; (147()):109432 doi:10.1016/j.yebeh.2023.109432.
PMID: 37716324 - 9
Drugs Causing Bone Loss.
Vestergaard P
Handbook of experimental pharmacology 2020; (262()):475-497 doi:10.1007/164_2019_340.
PMID: 31889220 - 10
Risk for osteoporosis and fracture with glucocorticoids.
Urquiaga M, Saag KG
Best practice & research. Clinical rheumatology 2022; (36(3)):101793 doi:10.1016/j.berh.2022.101793.
PMID: 36347775 - 11
Effects of repeated administration of rifampicin and isoniazid on vitamin D metabolism in mice.
Sheng L, Xue Y, He X, et al.
Steroids 2015; (104()):203-7.
PMID: 26476181 - 12
CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations.
Hawkes CP, Li D, Hakonarson H, et al.
The Journal of clinical endocrinology and metabolism 2017; (102(5)):1440-1446 doi:10.1210/jc.2016-4048.
PMID: 28324001 - 13
Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.
Nylén H, Habtewold A, Makonnen E, et al.
Medicine 2016; (95(34)):e4631 doi:10.1097/MD.0000000000004631.
PMID: 27559961 - 14
Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy.
Coelho L, Cardoso SW, Luz PM, et al.
Nutrition journal 2015; (14()):81 doi:10.1186/s12937-015-0072-6.
PMID: 26283663 - 15
Vitamin D Deficiency and Metabolism in HIV-Infected and HIV-Uninfected Men in the Multicenter AIDS Cohort Study.
Zhang L, Tin A, Brown TT, et al.
AIDS research and human retroviruses 2017; (33(3)):261-270 doi:10.1089/AID.2016.0144.
PMID: 27700140 - 16
Orlistat Therapy for Children With Type 1 Hyperlipoproteinemia: A Randomized Clinical Trial.
Patni N, Quittner C, Garg A
The Journal of clinical endocrinology and metabolism 2018; (103(6)):2403-2407 doi:10.1210/jc.2018-00369.
PMID: 29659879 - 17
Evaluating the real-world safety of cholestyramine for the treatment of hyperlipidemia: disproportionality analysis of FAERS data.
Li Q, Fan M, Gao A, Qin L
Frontiers in medicine 2026; (13()):1765949 doi:10.3389/fmed.2026.1765949.
PMID: 41756368 - 18
Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis.
Malihi Z, Wu Z, Stewart AW, et al.
The American journal of clinical nutrition 2016; (104(4)):1039-1051 doi:10.3945/ajcn.116.134981.
PMID: 27604776 - 19
The Safety Profile of Vitamin D Supplements Using Real-World Data from 445,493 Participants of the UK Biobank: Slightly Higher Hypercalcemia Prevalence but Neither Increased Risks of Kidney Stones nor Atherosclerosis.
Sha S, Degen M, Vlaski T, et al.
Nutrients 2024; (16(14)) doi:10.3390/nu16142251.
PMID: 39064694 - 20
The effect of calcium in water hardness on digoxin plasma levels in an experimental rat model.
Shahsavand S, Moshirfar M, Seyed-Sharifi SH, et al.
ARYA atherosclerosis 2020; (16(5)):235-243 doi:10.22122/arya.v16i5.2112.
PMID: 33889190 - 21
Machine Learning-Based Prediction of Digoxin Toxicity in Heart Failure: A Multicenter Retrospective Study.
Asai Y, Tashiro T, Kondo Y, et al.
Biological & pharmaceutical bulletin 2023; (46(4)):614-620 doi:10.1248/bpb.b22-00823.
PMID: 37005306 - 22
Management of digoxin toxicity.
Pincus M
Australian prescriber 2016; (39(1)):18-20 doi:10.18773/austprescr.2016.006.
PMID: 27041802
This information about vitamin D supplement interactions is for educational purposes only and is not medical advice. Ask your clinician or pharmacist before changing any medicine, supplement dose, or timing.
Get notified when new evidence is published on vitamin D deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.